Our previous data [17,18] demonstrated that BMSCs from MDS patients display an abnormal expression of focal adhesion kinase (FAK), an intracellular master regulator of cell adhesion [19,20]. This evidence concerns the gene PTK2 and myelodysplastic syndrome.